« FDA Approvals - Many Transvaginal Mesh Device 510(K) Approvals Were Based on Defective | Main | FDA approves system to repair abdominal aneurysms in people with »

FDA Draft Guidance Should Focus on "Companion Biomarkers" and Provide


FDA Draft Guidance Should Focus on "Companion Biomarkers" and Provide for Use of LDTs
The Association for Molecular Pathology (AMP) submitted comments to the Food and Drug Administration (FDA) regarding the FDA's "Draft Guidance for Industry and Food and Drug Administration Staff - In Vitro Companion Diagnostic Devices".
 

©2006 FDA-News.com. All rights reserved.